Saline Hydrodissection Shows Longer Symptom Relief Than Steroid Injections in Small Trial
Typing with numb fingers, struggling to grip everyday objects or waking up with an aching hand can make ordinary activities difficult for people with carpal tunnel syndrome. The condition develops when the median nerve becomes compressed as it passes through a narrow passage of bones and ligaments in the wrist. This pressure can cause pain, tingling, numbness and weakness in the affected hand.
A new clinical study suggests that a minimally invasive saline injection procedure may provide longer-lasting symptom relief than conventional steroid injections. The technique, known as hydrodissection, involves injecting fluid around the compressed nerve to gently separate it from surrounding tissues. The goal is to reduce pressure and friction, allowing the nerve to move more freely.
How the saline procedure works
During hydrodissection, clinicians use ultrasound imaging to guide a thin needle alongside the compressed median nerve. Sterile saline is then carefully injected around the nerve, creating space between it and the surrounding tissues.
The procedure is minimally invasive, is performed using local anesthesia and typically takes approximately 15 minutes.
Conventional corticosteroid injections primarily aim to reduce inflammation and swelling within the narrow carpal tunnel. Hydrodissection, by contrast, focuses on changing the physical environment surrounding the nerve.
Radiologist Anupama Tandon, who was involved in the study, explained that relieving pressure around the nerve through this technique may help reduce symptoms and improve hand function.
Inside the small Indian trial
The research team, led by radiologist Anindita Bose at Mahatma Gandhi Medical College and Hospital in India, recruited 39 adults who had experienced carpal tunnel symptoms for more than three months.
All participants had previously tried conservative treatments, including medication or wrist splints, without obtaining sufficient relief.
Because some participants had symptoms affecting both hands, the study included a total of 63 affected wrists.
Each wrist was randomly assigned to one of three ultrasound-guided treatment groups.
The first group received hydrodissection using saline alone, with the aim of separating the median nerve from adjacent tissues.
The second group received a corticosteroid injection without hydrodissection.
The third group underwent hydrodissection using a mixture of saline and corticosteroid, together with a local anesthetic.
This design allowed the researchers to compare the effects of mechanically separating the nerve from surrounding tissues with those of steroid treatment alone or a combination of both approaches.
What the results revealed
All three treatments initially improved symptoms, including pain, numbness and difficulties with hand function.
However, differences emerged during the following months. Participants receiving steroid injections alone tended to experience a return of pain sooner, while those treated with saline-only hydrodissection continued to report symptom relief for up to six months.
Adding corticosteroids to hydrodissection did not provide a clear additional benefit compared with saline hydrodissection alone.
Ultrasound examinations also revealed differences between the groups. Both hydrodissection treatments were associated with greater reductions in median nerve swelling than steroid injections without hydrodissection.
These findings suggest that physically separating the nerve from surrounding tissues may contribute to symptom improvement, beyond the anti-inflammatory effects associated with corticosteroids.
However, the trial did not include a placebo or sham-procedure group. As a result, the researchers could not fully distinguish the specific treatment effects from possible influences such as patient expectations or other nonspecific effects of receiving an injection.
Although the ultrasound findings support a possible physiological benefit, larger controlled studies are needed to establish the effectiveness of the procedure more confidently.
Patient experience and safety profile
Clinicians involved in the research described individual cases in which hydrodissection appeared to improve patients' everyday functioning.
One young typist had experienced persistent hand pain and numbness despite trying medication and a wrist splint. Her symptoms had begun interfering with her ability to work comfortably.
Following hydrodissection, she reported sufficient improvement to return to typing with less discomfort.
The treatments were performed on an outpatient basis, and participants did not need to remain in the hospital overnight.
No serious complications were reported during the study. Some participants experienced temporary discomfort or swelling around the injection site, but these symptoms generally resolved within several days.
One participant reported tingling during needle placement. However, the researchers did not observe any lasting nerve damage.
While these findings are reassuring, the relatively small number of participants means the study cannot establish the frequency of uncommon complications.
How it compares with existing options
Carpal tunnel syndrome is commonly managed with conservative treatments such as wrist splints, medications, physical therapy and corticosteroid injections.
For patients with severe symptoms, progressive nerve damage or persistent problems despite nonsurgical treatment, carpal tunnel release surgery is an established treatment. The operation relieves pressure on the median nerve by cutting the transverse carpal ligament.
However, some patients may benefit from less invasive approaches before considering surgery, particularly when their symptoms are mild or moderate.
The researchers emphasize that hydrodissection should not be regarded as a replacement for surgery in advanced cases.
Tandon suggested that the technique may be most useful for patients with mild to moderate carpal tunnel syndrome, for whom reducing nerve compression could potentially delay or avoid the need for an operation.
Nevertheless, larger multicenter clinical trials are necessary to determine how consistently the procedure works, how long its benefits persist and which patients are most likely to respond.
Next steps for research
The current study followed participants for six months, leaving uncertainty about whether symptom relief continues beyond that period.
The research team has begun a longer investigation comparing saline hydrodissection with injections using dextrose, a sugar-based solution that is increasingly being studied for ultrasound-guided nerve procedures.
Preliminary research involving other nerve-related conditions suggests that dextrose injections may offer additional pain relief in some circumstances, although their effectiveness for carpal tunnel syndrome requires further investigation.
Independent experts caution that the small sample size limits the strength and generalizability of the findings.
Training requirements and regulatory standards for ultrasound-guided nerve procedures also differ between countries, which may influence how widely the technique can be offered.
Nevertheless, the results contribute to growing interest in image-guided, minimally invasive treatments designed to relieve nerve compression while preserving surrounding tissues.
Carpal tunnel syndrome is among the most common peripheral nerve compression disorders worldwide. Even modest improvements in nonsurgical treatment could therefore benefit substantial numbers of patients.
If future studies confirm the findings, saline hydrodissection may become a relatively inexpensive and minimally invasive option for people who have not responded adequately to conservative treatment but do not yet require surgery.
The study, published in Radiology, adds to ongoing research exploring image-guided approaches to peripheral nerve entrapment. Further high-quality evidence will be needed before the procedure's place alongside established treatments can be determined.
